Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden · Delayed Price · Currency is SEK 441.00
+7.00 (1.61%)
May 6, 2026, 5:29 PM CET
STO:SOBI Market Cap
STO:SOBI has a market cap or net worth of 150.1 billion as of May 6, 2026. Its market cap has increased by 65.34% in one year.
Market Cap
150.10B
Enterprise Value
168.22B
Revenue
28.96B
Ranking
n/a
PE Ratio
164.45
Stock Price
441.00
Market Cap Chart
Since September 15, 2006, STO:SOBI's market cap has increased from 4.83B to 150.10B, an increase of 3,008.73%. That is a compound annual growth rate of 19.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 150.10B | 30.86% |
| Dec 30, 2025 | 114.70B | 4.06% |
| Dec 30, 2024 | 110.22B | 20.19% |
| Dec 29, 2023 | 91.70B | 41.80% |
| Dec 30, 2022 | 64.67B | 16.86% |
| Dec 30, 2021 | 55.34B | 12.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.85B |
| Cereno Scientific AB | 1.79B |
| EQL Pharma AB | 1.41B |
| Orexo AB | 680.27M |
| Enzymatica AB | 606.84M |
| Dicot Pharma AB | 590.75M |
| Nanexa AB | 588.39M |
| Cinclus Pharma Holding AB | 552.87M |